Page 8 - Data Coordinating Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Position Summary Reporting to the PHIA Project Director, the Associate Research Scientist (Technical Specialist) is responsible for managing the day-to-day aspects of selected country-specific Population-based HIV Impact Assessments (PHIA) Project survey activities at ICAP. In this capacity the Associate Research Scientist provides technical direction and support to PEPFAR, Ministries of Health and other local partners to design and implement population-based surveys in order to assess the impact of PEPFAR-supported HIV prevention, care and treatment programs. Assists the Project Director to ...

Francesca Belouad, MA, is a Research Psychologist in GEB-SDGE. She is responsible for administrating interviews and overseeing clinical aspects of the NIMH Family Study. Francesca has been employed as a Research Psychologist at the NIMH since 2000, when she was recruited by Dennis Charney, MD, during the formation of the Mood and Anxiety Disorders Research Program. Prior to this, she held research positions at the Section on Development Psychology at the NIMH, Outpatient Psychiatry at the Washington Veterans Medical Center, and the Department of Medical and Clinical Psychology at the Uniform...

 E-Mail IMAGE: The free high-resolution photo of writing, hand, number, line, measure, weight, fitness, measurement, close up, font, handwriting, organ, calligraphy, scales, shape, loss, emotion, pound, measuring, weight scale, weight loss, overweight... view more  Credit: Pxhere (Image Link: https://pxhere.com/en/photo/613480?fbclid=IwAR3Ep8o7jJEgv) A new genetic study of Native Hawaiians by Charleston Chiang at the University of Southern California and colleagues finds that people who have a greater proportion of Polynesian ancestry in their genomes face a higher risk of obesity, ...

Share this article Share this article ROCKVILLE, Md., Dec. 14, 2020 /PRNewswire/ -- Emmes today announced that it has conducted the data and statistical analysis for the second iteration of the Adaptive COVID-19 Treatment Trial (ACTT-2).  The ACTT-2 trial assessed the efficacy and safety of a 4-mg dose of baricitinib with remdesivir, versus remdesivir alone, in hospitalized COVID-19 patients. Baricitinib, produced by Eli Lilly and Company, has been used to treat adults with moderate to severe rheumatoid arthritis.  Baricitinib, in combination with remdesivir for COVID-19 patients, received...